Social, political, and economic environments around the world continue to evolve at an ever-increasing pace. It has become increasingly difficult to see where the world is headed in these times of turbulent, unpredictable change. Especially, the world is grappling with the COVID-19 pandemic, an occurrence that is likely to at least partially define, or redefine, our era regarding healthcare, but also society at large, the economy and politics. While uncertainty clouds the future, Otsuka remains steadfastly committed to addressing the desire of people for good health as the philosophical foundation of our business.
In 2019, we launched our Third Medium-term Management Plan. It projects five years of global growth sustained by Otsuka’s position as unique, total healthcare company. Emphasis is on our pharmaceutical and nutraceutical* businesses, with initiatives to maximize the value of existing business assets as well as creating new value. Furthermore, we will continue to manage with a corporate-wide awareness of capital costs to achieve sustainable growth. In our pharmaceutical business, our four designated global products are growing steadily in the fields of psychiatry and neurology; cardiovascular and renal systems; and oncology. In our nutraceutical* business, our core brands are growing in spite of adverse weather and intensifying competition. We are also proceeding with productivity-enhancement measures throughout our organization.
In recent years, companies have been increasingly called upon to vigorously advance corporate social responsibility (CSR) as evident from the rising social demand for greater environmental, social, and governance (ESG) investing and the universal adoption by UN member states of the Sustainable Development Goals (SDGs). At Otsuka, we dedicate ourselves to addressing and resolving social issues through business activities that are true to our corporate philosophy. By doing so, we aim to maintain our own growth while helping society become healthier and more sustainable. For example, we contribute to the betterment of public health through development of regimens for treatment of tuberculosis. We also host health seminars that draw upon on our extensive know-how. In such ways, we will continue to endeavor to do what only Otsuka can.
Based on the corporate philosophy of “Otsuka-people creating new products for better health worldwide”, we will continue as a comprehensive global health-care company, continually creating innovative products and services as we aim for continued growth.
We deeply appreciate your ongoing support.
President and Representative Director, CEO
- * Nutraceuticals = nutrition + pharmaceuticals